Affordable Access

[Value of the determination of erythrocyte haloperidol ketone reductase activity in the evaluation of haloperidol therapy].

Authors
  • Dutoit, D
  • Leroux, J M
  • Vaiva, G
  • Mohamed, Y
  • Thomas, P
  • Pommery, J
  • Taret, I
  • Bianchi-Decaix, I
  • Erb, F
  • Goudemand, M
Type
Published Article
Journal
Thérapie
Publication Date
Jan 01, 1994
Volume
49
Issue
1
Pages
71–74
Identifiers
PMID: 8091373
Source
Medline
License
Unknown

Abstract

Serum levels of haloperidol and reduced haloperidol as well as the reduced haloperidol/haloperidol ratios were determined in nine acute schizophrenics on oral haloperidol medication and correlated over 21 days with psycho pathology and extra-pyramidal symptom scores. We have investigated red blood cells haloperidol reductase activity in the group of patients. Significant correlations were found between haloperidol plasma levels and positive sub scale for each patient (r = 0.86 and p < 0.01; r = 0.70 and p < 0.05). We found a correlation between red blood cells reductase activity and the improvement of the psychotic anxiety scale (r = 0.64/and p < 0.05; r = 0.67 and p < 0.05), but not with reduced haloperidol/haloperidol ratios in plasma. The knowledge of reductase activity could predict the treatment response in acute schizophrenic patients. We suggest that the reported inter individual and inter ethnic differences in haloperidol and reduced haloperidol and in clinical response and adverse effects may be a reflection of genetic control of the two oxidative pathways mediated by cytochrome P450 isozyme and/or the reductase pathway mediated by haloperidol reductase in individual subject.

Report this publication

Statistics

Seen <100 times